Get started
Author

César Jiménez

Observed names: C Jimenez, C Jiménez, C. Jimenez, C. Jiménez, Cesar Jimenez, Cesar Jiménez, César Jimenez, César Jiménez Hernández, Jimenez, Cesar, Jiménez Hernández, César
ORCID: 0000-0003-2455-2048
Observed ORCID: 0000-0003-2455-2048
OpenAlex ID: A5057445201
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology
2020 · Jonel Trebicka, Javier Fernandez, et al. · Journal of Hepatology · 556
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis
2020 · Jonel Trebicka, Javier Fernandez, et al. · Journal of Hepatology · 316
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial
2019 · Elisa Pose, Laura Napoleone, et al. · The Lancet. Gastroenterology & hepatology · 156
Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)
2023 · Emmanuel Weiss, Carlos de la Peña-Ramirez, et al. · Gut · 57
PDF
Simvastatin and Rifaximin in Decompensated Cirrhosis
2025 · Elisa Pose, César Jiménez, et al. · JAMA · 53
Effect of rifaximin on infections, acute‐on‐chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA‐AH)
2022 · César Jiménez, Meritxell Ventura‐Cots, et al. · Liver International · 49
PDF
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium
2020 · Elsa Solà, Elisa Pose, et al. · Journal of Hepatology · 41
PDF
MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis
2023 · Luis Antonio Díaz, Eduardo Fuentes-López, et al. · JHEP Reports · 39
PDF
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis
2023 · Adrià Juanola, Ann Thu Ma, et al. · Gut · 37
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis
2021 · Elisa Pose, Elsa Solà, et al. · Hepatology Communications · 28
PDF
Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study
2025 · Kavish R Patidar, Ann T Ma, et al. · The Lancet. Gastroenterology & hepatology · 26
Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis
2024 · Jinxia Liu, Jane MacNaughtan, et al. · Gut · 23
An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study
2024 · Winston Dunn, Yanming Li, et al. · Hepatology · 21
Simvastatin plus Rifaximin to prevent ACLF in patients with decompensated cirrhosis. A randomised, double-blind, placebo-controlled, phase-3 trial: the liverhope efficacy trial
2023 · Elisa Pose, César Jiménez, et al. · Journal of Hepatology · 12
The role of liver steatosis as measured with transient elastography and transaminases on hard clinical outcomes in patients with COVID-19
2021 · Isabel Campos-Varela, Ares Villagrasa, et al. · Therapeutic Advances in Gastroenterology · 9
PDF
O09 A double blind, randomised, placebo-controlled study to assess safety and tolerability of oral enterosorbent Carbalive (Yaq-001) in cirrhotic patients
2021 · Jane Macnaughtan, Agustin Albillos, et al. · Gut · 8
PDF
Prophylactic antibiotics in patients with alcohol‐associated hepatitis receiving steroids: A systematic review and meta‐analysis
2024 · Joo Wei E. Quek, Jing Hong Loo, et al. · Liver International · 7
PDF
Real-World Use of Terlipressin in Cirrhosis and Acute Kidney Injury: Frequent Use Beyond Hepatorenal Syndrome
2025 · Ann T. Ma, Adrià Juanola, et al. · Clinical Gastroenterology and Hepatology · 6
PDF
Bacterial Infection Features in Alcohol-Associated Hepatitis: Review of a 2016–2021 Cohort
2024 · Cesar Jimenez, Aina Martí-Carretero, et al. · Journal of Clinical Medicine · 4
PDF
Severity of gastrointestinal bleeding is similar between patients receiving direct oral anticoagulants or vitamin K antagonists
2022 · Luis Alcalá-González, César Jiménez, et al. · Revista Española de Enfermedades Digestivas · 4
Endoscopic stenting for gastroduodenal outlet obstruction of a malignant origin, real life experience in a single center
2020 · Luis Alcalá-González, Miquel Masachs Perecaula, et al. · Revista Española de Enfermedades Digestivas · 4
Use of rifaximin in alcoholic hepatitis: Pilot study
2018 · C. Jimenez, M. Ventura, et al. · Journal of Hepatology · 4
TOP-218 Yaq-001 positively impacts gut microbiome composition, virulence, antimicrobial resistance gene profile resulting in significant effects on ammonia, endotoxemia and inflammation in cirrhosis patients
2025 · Jinxia Liu, Jose G. Guevara, et al. · Journal of Hepatology · 1
O-25 Assessment of Models for Predicting Response to Corticoids Treatment in Alcohol-associated Hepatitis: a Global Cohort Study
2023 · Francisco Idalsoaga, Luis Antonio Díaz, et al. · Annals of Hepatology · 1
Impact of YAQ001 on the Gut Microbiome, Permeability and Markers of Systemic Inflammation in Patients With Cirrhosis
2026 · Jinxia Liu, Fernando Garcia-Guevara, et al. · Liver International
PDF
Works count: 47
Citation count: 1,462
H-index: 13
I10-index: 14
Year
Topic
Type